Nephros (FRA:NPJP) Short-Term Debt : €0.00 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Nephros Short-Term Debt?

Nephros's Short-Term Debt for the quarter that ended in Mar. 2024 was €0.00 Mil.

Nephros's annual Short-Term Debt declined from Dec. 2021 (€0.22 Mil) to Dec. 2022 (€0.07 Mil) and declined from Dec. 2022 (€0.07 Mil) to Dec. 2023 (€0.00 Mil).

Nephros Short-Term Debt Historical Data

The historical data trend for Nephros's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nephros Short-Term Debt Chart

Nephros Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Debt

Get a 7-Day Free Trial

0.69

0.19

0.22

0.07

Nephros Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Debt	Get a 7-Day Free Trial															-	-	-	-	-

Nephros Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Nephros Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Nephros's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Nephros (FRA:NPJP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nephros Inc (FRA:NPJP) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

NEPH:USA

Address

380 Lackawanna Place, South Orange, NJ, USA, 07079

Website

https://www.nephros.com

Nephros Inc is a commercial-stage company that develops and sells high performance water solutions to the medical and commercial markets. In medical markets, it sell water filtration products and waterborne pathogen detection products. In commercial markets, the company manufacture and sell water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The operating segments of the group are Water Filtration, Pathogen Detection and Renal Products of which key revenue is derived from Water Filtration segment.

Nephros (FRA:NPJP) Headlines

No Headlines